{{Rsnum
|rsid=9836484
|Chromosome=3
|position=77995538
|Orientation=plus
|GMAF=0.3567
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 14.2 | 40.7 | 45.1
| HCB | 19.0 | 50.4 | 30.7
| JPT | 24.8 | 46.9 | 28.3
| YRI | 16.3 | 44.9 | 38.8
| ASW | 10.5 | 45.6 | 43.9
| CHB | 19.0 | 50.4 | 30.7
| CHD | 18.3 | 52.3 | 29.4
| GIH | 5.9 | 36.6 | 57.4
| LWK | 10.9 | 50.9 | 38.2
| MEX | 3.4 | 31.0 | 65.5
| MKK | 16.0 | 61.5 | 22.4
| TSI | 10.8 | 39.2 | 50.0
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19023125
|Trait=Brain imaging in schizophrenia (interaction)
|Title=A Genome-Wide Association Study of Schizophrenia Using Brain Activation as a Quantitative Phenotype
|RiskAllele=
|Pval=0.000004
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs9836484
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19023125; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: A Genome-Wide Association Study of Schizophrenia Using Brain Activation as a Quantitative Phenotype. (Initial Sample Size: 64 cases, 74 cases; Replication Sample Size: NR); (Region: 3p12.3; Reported Gene(s): ROBO2, ROBO1; Risk Allele: rs9836484-?); (p-value= 0.000004).This variant is associated with Brain imaging in schizophrenia (interaction).
|Drugs=
|Drug Classes=
|Diseases=Schizophrenia
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740326
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9836484
|overall_frequency_n=48
|overall_frequency_d=128
|overall_frequency=0.375
|n_genomes=33
|n_genomes_annotated=0
|n_haplomes=41
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}